These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 15467034)

  • 101. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
    J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
    [TBL] [Abstract][Full Text] [Related]  

  • 102. From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.
    Okano M; Gross TG
    Pediatr Hematol Oncol; 2001; 18(7):427-42. PubMed ID: 11594706
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
    Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
    Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
    [TBL] [Abstract][Full Text] [Related]  

  • 104. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.
    Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K
    J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest.
    Okan I; Wang Y; Chen F; Hu LF; Imreh S; Klein G; Wiman KG
    Oncogene; 1995 Sep; 11(6):1027-31. PubMed ID: 7566960
    [TBL] [Abstract][Full Text] [Related]  

  • 106. AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway.
    Escobar-Díaz E; López-Martín EM; Hernández del Cerro M; Puig-Kroger A; Soto-Cerrato V; Montaner B; Giralt E; García-Marco JA; Pérez-Tomás R; Garcia-Pardo A
    Leukemia; 2005 Apr; 19(4):572-9. PubMed ID: 15744353
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Sugimoto M; Tahara H; Ide T; Furuichi Y
    Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
    Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
    Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
    Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
    Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.
    Niedobitek G; Agathanggelou A; Finerty S; Tierney R; Watkins P; Jones EL; Morgan A; Young LS; Rooney N
    Am J Pathol; 1994 Oct; 145(4):969-78. PubMed ID: 7943186
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse.
    Murakami M; Hoshikawa Y; Satoh Y; Ito H; Tajima M; Okinaga K; Miyazawa Y; Kurata T; Sairenji T
    Virology; 2000 Nov; 277(1):20-6. PubMed ID: 11062032
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression.
    Wu ZZ; Chow KP; Kuo TC; Chang YS; Chao CC
    Biochem Pharmacol; 2011 Dec; 82(12):1860-72. PubMed ID: 21945668
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Comparative proteomic analysis implicates COMMD proteins as Epstein-Barr virus targets in the BL41 Burkitt's lymphoma cell line.
    Gkiafi Z; Panayotou G
    J Proteome Res; 2011 Jul; 10(7):2959-68. PubMed ID: 21615174
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.
    Iwata S; Yano S; Ito Y; Ushijima Y; Gotoh K; Kawada J; Fujiwara S; Sugimoto K; Isobe Y; Nishiyama Y; Kimura H
    Int J Cancer; 2011 Nov; 129(9):2263-73. PubMed ID: 21170988
    [TBL] [Abstract][Full Text] [Related]  

  • 117. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.
    Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 119. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
    Chen Y; Chen XY
    Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
    J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.